Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment

Oral Oncol. 2017 Jan:64:e1-e3. doi: 10.1016/j.oraloncology.2016.10.020. Epub 2016 Nov 3.

¹ Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU, Bordeaux, France; Bordeaux University, Bordeaux, France. Electronic address: [email protected].
² Department of Otolaryngology - Head and Neck Surgery, Pellegrin Hospital, University Hospital, CHU, Bordeaux, France.
³ Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU, Bordeaux, France.
⁴ Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU, Bordeaux, France; Bordeaux University, Bordeaux, France.
⁵ Department of Radiation Therapy, Haut Leveque Hospital, University Hospital, CHU, Bordeaux, France.
⁶ Neuroradiology Department, Pellegrin Hospital, University Hospital, CHU, Bordeaux, France.

No abstract available

Keywords: Head and neck cancer; Oral cancer.

Publication types